Navigation Links
Determined a new method to establish the antioxidant capacity of extra virgin olive oil
Date:4/30/2008

This release is available in Spanish.

A group of scientists from the Nutrition and Food Science Department from the Faculty of Pharmacy of the University of Granada have reported the beneficial effects of extra virgin olive oil on human health, determining in vitro and in vivo the antioxidant power that the examined extra virgin olive oil samples present. With this work, researchers have found out a more effective method nowadays in order to establish the antioxidant capacity of extra virgin olive oil.

Research has been directed by doctors M. Carmen Lpez Martnez, Herminia Lpez Garca de La Serrana and Jos Javier Quesada Granados, and its main author is Cristina Samaniego Snchez. The scientists have prepared four methods that let us know know the antioxidant capacity and he beneficial effect of the extra virgin olive oil obtained from olives of the Picual variety.

Work "in vitro"

In order to carry out this work, they determined the best method to calculate the in vitro antioxidant capacity in oil samples. They concluded that, among all the applied methods, the ABTS was the most suitable in order to study this kind of samples as it shows the correlation with the total polyphenol index in a better way. Moreover, scientists observed that the reproducibility of the results of these methods is good and that the variation coefficients obtained by the different methods are acceptable, which makes it possible to conclude, generally, that the four studied methods could be applied to measure the antioxidant oil capacity.

Scientists from Granada are not discarding the idea of registering some patents related to this research soon, since they already have experience in getting patents related
'/>"/>

Contact: Cristina Samaniego Snchez
csama@ugr.es
34-958-243-863
Universidad de Granada
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Determined to Quit Week to Help Pennsylvanians Follow Through With Resolutions to Stop Using Tobacco
2. Kidney cancer surgery often determined by surgeons practice style, not medical factors
3. Breech Birth May Be Determined by Genes
4. Stanford study highlights cost-effective method of lowering heart disease risks
5. Different method of evaluating the urinary tract system reduces radiation dose
6. Report on patients access to cancer drugs uses flawed methods to reached flawed conclusions
7. A classic method for modeling skin cancer is featured in Cold Spring Harbor Protocols
8. Researcher developing new method for hearing loss assessment
9. Medicare Prescription Drug Benefit, Nonprofit Hospitals, Ambulatory Surgery Centers, Statistical Methods, and Pay-For-Performance Highlighted In the Latest INQUIRY Journal
10. GPS-like technology helps pinpoint best methods for moving injured players
11. New Seminar Series from Activator Methods Teaches Doctors a Unique Approach to Improving Nations Chiropractic Care: Focus on the Patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/1/2008)...ies support providers in discussing health care co...As health care costs continue to rise, many employ...o their employees through higher premiums or cost-... and coinsurance. To help consumers better underst...viders, such as primary care physicians, specialis...
(Date:12/1/2008)...Medicare Prescription Drug Enrollment Period Is Ha... WASHINGTON, Dec. 1 The...nt period is nearly halfway over - running from No...nt period is an opportunity for seniors to change ... currently enrolled or for those not enrolled in a...
(Date:12/1/2008)...Dec. 1 Sciton introduces ProLipo,...a high-powered laser system,for ablating and melt... and,tissue tightening. ProLipo PLUS combines 10...timal body sculpting results. Frequently used as ...o be utilized as a standalone procedure,for patie...
(Date:12/1/2008)...R HONORED FOR CAREER OF SCIENTIFIC DISCOVERY IN MO... The Radiologic Society of North Am...th its "Outstanding Researcher of The Year" Award,...o has made original significant contributions to t...rch. Dr. Weissleder is Professor at Harvard Medic...
Breaking Medicine News(10 mins):Health News:Don't Know How Much an X-Ray Costs You? Highmark Network Providers Will Begin Having Conversations With Highmark Members About Their Actual Cost of Care 2Health News:Don't Know How Much an X-Ray Costs You? Highmark Network Providers Will Begin Having Conversations With Highmark Members About Their Actual Cost of Care 3Health News:Don't Know How Much an X-Ray Costs You? Highmark Network Providers Will Begin Having Conversations With Highmark Members About Their Actual Cost of Care 4Health News:Radio Interview Opportunity: Important News for Seniors 2Health News:Sciton Introduces ProLipo PLUS(TM), the Most Robust Laser-Assisted Lipolysis System Available 2Health News:VisEn Co-Founder Named Radiologic Society's 'Outstanding Researcher of the Year' 2Health News:VisEn Co-Founder Named Radiologic Society's 'Outstanding Researcher of the Year' 3
...ccessful cloning has been a dream come true for th...he U.S. Food and Drug Administration is expected t...unce soon that milk // from cloned animals, as wel... Canada holds the credit when it comes to cloning...
...u may expect your partner to inform you of his/her...e a legal stand on this. Even horrifying is the fa...to protect you // from the virus. The Wellington D...the charges of criminal nuisance against Justin Da...
...botic surgery could finally prove to be an answer ...the disease. Surgical treatment of prostate cancer...pain, scarring and a // reduction in the post-oper...s the second leading cause of death among American...
...rdasil is the new cervical vaccine developed by Sa... in its phase III trial, the vaccine is given in t...essful. The company is // to apply for a license t...lloma virus infection and also genital warts, whic...
Other Medicine News:Health News:Ruling On Non Disclosure Of HIV Positive Status Is Not Ethical 2Health News:Complete Robotic Surgery To Revolutionize Surgical Treatment of Prostate Cancer 2Health News:Gardasil vaccine for cervical cancer 2
(Date:11/25/2008).... 25 Proteolix, Inc., a,leader in...cs that target,protein degradation pathways in ca...t data from two ongoing Phase 2 clinical trials of...d at the upcoming 50th Annual Meeting of the,Amer...the first in a new class,of specific proteasome i...
(Date:11/25/2008)...l Trial to Assess Survival of Patients Receiving L...able Hepatocellular Carcinoma , , BELLEVUE,...ology, Inc. (LSO) today announced the completion o... Light Infusion Therapy(TM) (Litx(TM)) as a treatm...), also known as hepatoma or primary liver cancer....
(Date:11/24/2008)...swire/ -- Domino,s Pizza (NYSE: DPZ ), the,reco...up to raise dough for,the kids of St. Jude Childr...anks and Giving campaign. Domino,s customers will ...of purchase to benefit the children of St. Jude.,... or when ordering online at, www.dominos.com . Th...
(Date:11/24/2008)... leadership and long-term commitment to hepatitis ...ewswire-FirstCall/ -- Schering-Plough Corporation ... boceprevir, its lead investigational oral hepatit...elopment. The company believes boceprevir has the...s protease inhibitor for treating chronic hepatiti...
Breaking Medicine Technology:Proteolix to Present Clinical and Preclinical Data at the 50th Annual Meeting of the American Society of Hematology 2Proteolix to Present Clinical and Preclinical Data at the 50th Annual Meeting of the American Society of Hematology 3Light Sciences Oncology Completes Patient Enrollment in Phase 3 Clinical Trial of Litx as a Treatment for Hepatocellular Carcinoma 2Light Sciences Oncology Completes Patient Enrollment in Phase 3 Clinical Trial of Litx as a Treatment for Hepatocellular Carcinoma 3Light Sciences Oncology Completes Patient Enrollment in Phase 3 Clinical Trial of Litx as a Treatment for Hepatocellular Carcinoma 4Domino's Pizza Pledges Support to the Fifth Annual St. Jude Children's Research Hospital(R) Thanks and Giving(R) Campaign 2Domino's Pizza Pledges Support to the Fifth Annual St. Jude Children's Research Hospital(R) Thanks and Giving(R) Campaign 3Schering-Plough Provides Update on Boceprevir Clinical Development and Introduces Potent Next-Generation Oral HCV Protease Inhibitor for Treating Patients With Chronic Hepatitis C 2Schering-Plough Provides Update on Boceprevir Clinical Development and Introduces Potent Next-Generation Oral HCV Protease Inhibitor for Treating Patients With Chronic Hepatitis C 3Schering-Plough Provides Update on Boceprevir Clinical Development and Introduces Potent Next-Generation Oral HCV Protease Inhibitor for Treating Patients With Chronic Hepatitis C 4Schering-Plough Provides Update on Boceprevir Clinical Development and Introduces Potent Next-Generation Oral HCV Protease Inhibitor for Treating Patients With Chronic Hepatitis C 5Schering-Plough Provides Update on Boceprevir Clinical Development and Introduces Potent Next-Generation Oral HCV Protease Inhibitor for Treating Patients With Chronic Hepatitis C 6Schering-Plough Provides Update on Boceprevir Clinical Development and Introduces Potent Next-Generation Oral HCV Protease Inhibitor for Treating Patients With Chronic Hepatitis C 7Schering-Plough Provides Update on Boceprevir Clinical Development and Introduces Potent Next-Generation Oral HCV Protease Inhibitor for Treating Patients With Chronic Hepatitis C 8Schering-Plough Provides Update on Boceprevir Clinical Development and Introduces Potent Next-Generation Oral HCV Protease Inhibitor for Treating Patients With Chronic Hepatitis C 9Kaiser Foundation Health Plan and Hospitals Reports Fourth Quarter and Fiscal Year End 2007 Financial Results 11912 1Kaiser Foundation Health Plan and Hospitals Reports Fourth Quarter and Fiscal Year End 2007 Financial Results 11912 2Kaiser Foundation Health Plan and Hospitals Reports Fourth Quarter and Fiscal Year End 2007 Financial Results 11912 3Kaiser Foundation Health Plan and Hospitals Reports Fourth Quarter and Fiscal Year End 2007 Financial Results 11912 4GSK Launches New Website to Help Employers Lower Costs and Improve the Health of Workers 11910 1GSK Launches New Website to Help Employers Lower Costs and Improve the Health of Workers 11910 2GSK Launches New Website to Help Employers Lower Costs and Improve the Health of Workers 11910 3GSK Launches New Website to Help Employers Lower Costs and Improve the Health of Workers 11910 4Onyx Pharmaceuticals Announces Fourth Quarter and Full Year 2007 Financial Results Teleconference and Webcast 3307 1Onyx Pharmaceuticals Announces Fourth Quarter and Full Year 2007 Financial Results Teleconference and Webcast 3307 2Acute Coronary Events Drop After Italys Public Smoking Ban 11909 1Acute Coronary Events Drop After Italys Public Smoking Ban 11909 2
...., April 17, 2007,/PRNewswire-FirstCall/ -- Cell G...rom two previously conducted Phase 2 clinical tria...uation of antibody,responses in patients with adva... the GVAX cell-based immunotherapy induces,antibod...ssociated,antigens, including some not previously ...
...-Apr 17, 2007 - A 9-month, randomized,double-blin...mparing a 40 mg dose of COPAXONE(R) given daily to...wed a 38 percent greater,reduction in inflammatory...e images (MRI) of the brain. In addition, patients...an on-trial relapse rate,of 77 percent when compar...
Other Medicine Technology:Cell Genesys Reports GVAX Immunotherapy for Prostate Cancer Induces,a Broad, Patient-Specific Antibody Response 2Cell Genesys Reports GVAX Immunotherapy for Prostate Cancer Induces,a Broad, Patient-Specific Antibody Response 3Cell Genesys Reports GVAX Immunotherapy for Prostate Cancer Induces,a Broad, Patient-Specific Antibody Response 4Data Published in Neurology Showed That Higher Dose of Copaxone,Increased Efficacy in Relapsing-Remitting Multiple Sclerosis (RRMS) 2Data Published in Neurology Showed That Higher Dose of Copaxone,Increased Efficacy in Relapsing-Remitting Multiple Sclerosis (RRMS) 3Data Published in Neurology Showed That Higher Dose of Copaxone,Increased Efficacy in Relapsing-Remitting Multiple Sclerosis (RRMS) 4Data Published in Neurology Showed That Higher Dose of Copaxone,Increased Efficacy in Relapsing-Remitting Multiple Sclerosis (RRMS) 5
...al reference laboratory and a worldwide leader in ...UP offers an extensive test menu of highly complex... pathology. Owned by the University of Utah, ARUP ...e nation's university teaching hospitals and child...
...al reference laboratory and a worldwide leader in ...UP offers an extensive test menu of highly complex... pathology. Owned by the University of Utah, ARUP ...e nation's university teaching hospitals and child...
...al reference laboratory and a worldwide leader in ...UP offers an extensive test menu of highly complex... pathology. Owned by the University of Utah, ARUP ...e nation's university teaching hospitals and child...
...al reference laboratory and a worldwide leader in ...UP offers an extensive test menu of highly complex... pathology. Owned by the University of Utah, ARUP ...e nation's university teaching hospitals and child...
Medicine Products: